Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 96739 · Class II · Blood Bank Of Delmarva, a Division of New York Blood Center, Inc.
Key facts
| Event ID | 96739 |
|---|---|
| Recall numbers | B-0317-2025 |
| Recalling firm | Blood Bank Of Delmarva, a Division of New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Red Blood Cells, which tested repeatedly reactive for the antibody to Hepatitis B core antigen (Anti-HBc), was distributed. |
| Initiation date | Feb 5, 2025 |
| Report date | May 14, 2025 |
| Termination date | May 7, 2025 |
| City | Newark |
| State | DE |
| Country | United States |
| FEI number | 2577603 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: